Recruiting
Phase 2

Empagliflozin

Sponsor:

Yale University

Code:

NCT05726032

Conditions

Cirrhosis

Liver Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Empagliflozin 10 MG

Matching Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-30. This information was provided to ClinicalTrials.gov by Yale University on 2025-03-26.